Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.64
Delayed Data
As of Jul 31
 +0.02 / +0.76%
Today’s Change
0.33
Today|||52-Week Range
5.75
+560.00%
Year-to-Date

Today’s Trading

Previous close2.62
Today’s open2.64
Day’s range2.40 - 2.64
Volume1,160,243
Average volume (3 months)1,110,530
Market cap$95.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...+0.01+0.33%
RNNRexahn Pharmaceutica...+0.02+3.79%
ZSANZosano Pharma Corp+0.10+1.30%
PULMPulmatrix Inc+0.26+3.98%
Data as of 4:00pm ET, 07/31/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quebec

Forecasts